Accuracy of late-night salivary cortisol in evaluating postoperative remission and recurrence in Cushing’s disease
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
CONTEXT: Late-night salivary cortisol (LNSC) is well-validated in the diagnosis of Cushing's disease (CD). The accuracy of LNSC during follow-up of patients undergoing transsphenoidal surgery (TSS) has not been fully characterized. OBJECTIVES: We examined the accuracy of LNSC in establishing remission and identifying recurrence in postoperative patients with CD. DESIGN: This is a retrospective study. PATIENTS: Records of patients with CD who underwent TSS by a single neurosurgeon in our tertiary center (2005-2014) were analyzed (N = 224). Patients were selected for further investigation (n = 165) if there was at least one available LNSC test obtained after TSS (either within 3 months or during long-term follow-up). Extracted data included demographic and clinical characteristics, magnetic resonance imaging and laboratory data (morning serum cortisol, 24-hour urine free cortisol [UFC], LNSC) . MAIN OUTCOMES AND MEASURES: Remission was defined as nadir morning serum cortisol less than 5 mcg/dl and nadir 24-hour UFC less than 23 mcg. Recurrence was considered definite if confirmed surgically or prompted radiotherapy. RESULTS: Surgical remission occurred in 89% of 89 patients with available LNSC data. LNSC, obtained within 3 months of TSS, established remission with 94% sensitivity and 80% specificity at a cutpoint of 1.9 nmol/l (area under the curve [AUC] = 0.90). At a median follow-up of 53.5 months, LNSC established recurrence (75% sensitivity and 95% specificity) at a cutpoint of 7.4 nmol/l (AUC = 0.87), and 24-hour UFC established recurrence (68% sensitivity and 100% specificity) at a cutpoint of 1.6-fold above normal (AUC = 0.82). CONCLUSIONS: LNSC may accurately establish remission after TSS and identify recurrence more accurately than 24-hour UFC during long-term follow-up.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“loss of the nadir of cortisol secretion late at night is the earliest detectable biochemical abnormality in patients with recurrent CD often preceding elevations of urine cortisol or an abnormal low-dose DST [78, 80, 82, 83]”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [78]
In the citing paper
“as many as 30% to 50% of CD patients will have either persistent or recurrent hypercortisolism after initial pituitary surgery [78-81]”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [78]
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Self-citationRoelfsema, F., Biermasz, N. R., & Pereira, A. M. (2012) · Pituitary · doi:10.1007/s11102-011-0347-7 · Cited by 346
Trainer, P. J., Lawrie, H. S., Verhelst, J., Howlett, T. A., Lowe, D. G., Grossman, A. B., Savage, M. O., Afshar, F., & Besser, G. M. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00975.x · Cited by 267
Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease
Swearingen, B., Biller, B. M. K., Barker, F. G., Katznelson, L., Grinspoon, S., Klibanski, A., & Zervas, N. T. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00015 · Cited by 231
Self-citationYap, L. B., Turner, H. E., Adams, C. B. T., & Wass, J. A. H. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01444.x · Cited by 203
Measurement of salivary cortisol in 2012 – laboratory techniques and clinical indications
Inder, W. J., Dimeski, G., & Russell, A. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04508.x · Cited by 195
Late-night salivary cortisol as a screening test for cushing's syndrome
Raff, H. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2681 · Cited by 194
Esposito, F., Dusick, J. R., Cohan, P., Moftakhar, P., McArthur, D., Wang, C., Swerdloff, R. S., & Kelly, D. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1204 · Cited by 192
Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
Raff, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1166 · Cited by 186
Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee, G. H., Mathias, D. B., James, R. A., & Kendall‐Taylor, P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01261.x · Cited by 182
Cited by
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
“29–33 Because urine volume and glom erular filtration rate strongly predict UFC, other screening tests such as LNSC might be preferred for patients with renal impairment (creatinine clearance <60 mL/min) or clinically significant polyuria (>5 L/24 h).”
InfluentialSelf-citationGadelha, M., Gatto, F., Wildemberg, L. E., & Fleseriu, M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01961-x · Cited by 168
Current best practice in the management of patients after pituitary surgery
Prete, A., Corsello, S. M., & Salvatori, R. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018816687240 · Cited by 156
The experience with transsphenoidal surgery and its importance to outcomes
Honegger, J. B., & Grimm, F. (2018) · Pituitary · doi:10.1007/s11102-018-0904-4 · Cited by 100
Braun, L., Rubinstein, G., Zopp, S., Vogel, F., Schmid‐Tannwald, C., Escudero, M. P., Honegger, J. B., Ladurner, R., & Reincke, M. (2020) · Endocrine · doi:10.1007/s12020-020-02432-z · Cited by 97
Nieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 90
“Studies suggest that a bedtime salivary cortisol (after holding off administering any afternoon hydrocortisone replacement) is the first abnormality in recurrence, occurring before clinical signs of hypercortisolism 210,211 .”
An individualized approach to the management of Cushing disease
Fleseriu, M., Varlamov, E. V., Hinojosa‐Amaya, J. M., Langlois, F., & Melmed, S. K. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00868-7 · Cited by 80
Vassiliadi, D. A., & Tsagarakis, S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0007 · Cited by 75
Fleseriu, M., Hamrahian, A. H., Hoffman, A. R., Kelly, D. F., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161512.dscr · Cited by 68
Nishioka, H., & Yamada, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111951 · Cited by 65
“[189] concluded that late-night salivary cortisol levels may accurately establish remission after TSS and identify recurrence more accurately than 24-hour UFC during long-term follow up.”
BackgroundUse of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease
Newell-Price, J., Pivonello, R., Tabarin, A., Fleseriu, M., Witek, P., Gadelha, M. R., Petersenn, S., Tauchmanova, L., Ravichandran, S., Gupta, P., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0695 · Cited by 60
Self-citationTabarin, A., Assié, G., Barat, P., Bonnet, F., Bonneville, J. F., Borson-Chazot, F., Bouligand, J., Boulin, A., Brue, T., Caron, P., et al. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.02.001 · Cited by 59
Current management of Cushing's disease
Tritos, N. A., & Biller, B. M. K. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12975 · Cited by 60
Self-citationFleseriu, M., & Biller, B. M. K. (2022) · Pituitary · doi:10.1007/s11102-022-01268-2 · Cited by 54
“However, UFC and LNSC elevations may not always be concordant in recurrent CD; in many patients, LNSC becomes abnormal before UFC, by up to 1 year in some studies [1, 15].”
BackgroundSelf-citationHypercortisolemia Recurrence in Cushing’s disease; a diagnostic challenge
Hinojosa-Amaya, J. M., Varlamov, E. V., McCartney, S., & Fleseriu, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00740 · Cited by 45
“This suggests that LNSC also has some accuracy issues for diagnosing early recurrence of CD, although seems overall to be a better test than 24-h UFC (2, 12, 13, 17, 37).”
BackgroundCarroll, T. B., Javorsky, B. R., & Findling, J. W. (2016) · Endocrine Practice · doi:10.4158/ep161380.or · Cited by 41
Variability of late-night salivary cortisol in Cushing disease: a prospective study
Sandouk, Z., Johnston, P., Bunch, D., Wang, S., Bena, J., Hamrahian, A., & Kennedy, L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02020 · Cited by 39
“(20), in a retrospective study that included LNSC measurement in 68 patients with CD in remission after TSS, of whom 19 then had recurrence, concluded that LNSC would be a more convenient and more accurate test than 24-hour UFC for detecting recurrence.”
BackgroundValassi, E., Crespo, I., Keevil, B. G., Aulinas, A., Urgell, E., Vives, A. S., Trainer, P. J., & Webb, S. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0779 · Cited by 46
Kannankeril, J., Carroll, T., Findling, J. W., Javorsky, B., Gunsolus, I. L., Phillips, J., & Raff, H. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa107 · Cited by 36
“It is increasingly appreciated that as many as 30% to 50% of CD patients will have either persistent or recurrent hypercortisolism after initial pituitary surgery [78-81].”
BackgroundLong‐term follow‐up and predictors of recurrence of Cushing's disease
Guignat, L., & Bertherat, J. Y. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13186 · Cited by 36
“Amlashi et al.(42) analyzed the benefit of LNSC”
BackgroundInfluentialCapatina, C. A.-M., Hinojosa‐Amaya, J. M., Poiană, C., & Fleseriu, M. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1802243 · Cited by 34
Wang, F., Catalino, M. P., Bi, W. L., Dunn, I. F., Smith, T. R., Guo, Y., Hordejuk, D., Kaiser, U. B., Laws, E. R., & Min, L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa773 · Cited by 32
Vassiliadi, D. A., Balomenaki, M., Asimakopoulou, A., Botoula, E., Tzanela, M., & Tsagarakis, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2799 · Cited by 33
“8 g/dL) within 1 month from TSS were considered as having delayed remission (11); and 3) there were symptoms of adrenal insufficiency necessitating corticosteroid replacement or improvement in clinical features.”
BackgroundHarrison, R. F., Debono, M., Whitaker, M. J., Keevil, B. G., Newell-Price, J., & Ross, R. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01172 · Cited by 27
Ambrogio, A. G., Andrioli, M., De Martin, M., Cavagnini, F., & Pecori Giraldi, F. (2017) · Endocrine Connections · doi:10.1530/ec-17-0292 · Cited by 26
The definition of remission and recurrence of Cushing’s disease
Hinojosa‐Amaya, J. M., & Ramos, D. C. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101485 · Cited by 28
Pituitary-Directed Therapies for Cushing’s Disease
Langlois, F., Chu, J. M., & Fleseriu, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00164 · Cited by 28
“LNSC follow-up seems to be the most accurate compared with UFC, serum cortisol and plasma ACTH in predicting postoperative recurrence in CD (19, 45, 46).”
BackgroundFoshati, S., Ghanizadeh, A. J., & Akhlaghi, M. (2021) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2021.07.016 · Cited by 27
Tritos, N. A., Fazeli, P. K., McCormack, A. I., Mallea-Gil, S., Pineyro, M. M., Christ‐Crain, M., Frara, S., Labadzhyan, A., Ioachimescu, A. G., Shimon, I., et al. (2021) · Pituitary · doi:10.1007/s11102-021-01170-3 · Cited by 23
Self-citationCharacterization of cyclic Cushing's disease using late night salivary cortisol testing
Jahandideh, D., Swearingen, B., Nachtigall, L. B., Klibanski, A., Biller, B. M. K., & Tritos, N. A. (2018) · Clinical Endocrinology · doi:10.1111/cen.13758 · Cited by 21
Self-citationCushing's syndrome – Disease monitoring: Recurrence, surveillance with biomarkers or imaging studies
Ragnarsson, Ó. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101382 · Cited by 25
Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort
Viecceli, C., Mattos, A. C. V., Costa, M. C. B., de Melo, R. B., Rodrigues, T. D. C., & Czepielewski, M. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1017331 · Cited by 22
“In patients with active disease, to evaluate the ketoconazole treatment response, 24-h UFC was used as a laboratory parameter, as recommended in similar publications (14, 16, 20, 21), but in some cases, we considered elevated late night salivary cortisol and/or 1 mg dexamethasone overnight cortisol (even with normal 2…”
MethodOutcome of endoscopic vs microsurgical transsphenoidal resection for Cushing’s disease
Qiao, N. (2018) · Endocrine Connections · doi:10.1530/ec-17-0312 · Cited by 20
Influence of age, gender and body mass index on late-night salivary cortisol in healthy adults
Coelli, S., Farias, C. B., Soares, A. A., Crescente, G. M., Hirakata, V. N., Souza, L. B., Czepielewski, M. A., Camargo, J. L., & Silveiro, S. P. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-1100 · Cited by 19
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation
Jones, P. S., & Swearingen, B. (2022) · Pituitary · doi:10.1007/s11102-022-01254-8 · Cited by 16
Self-citationHinojosa-Amaya, J. M., González-Colmenero, F. D., Alvarez-Villalobos, N. A., Salcido-Montenegro, A., Quintanilla-Sánchez, C., Moreno-Peña, P. J., Manzanares-Gallegos, D. M., Gutiérrez-Dávila, L. F., Castillo-Morales, P. L., García-Campa, M., et al. (2024) · Pituitary · doi:10.1007/s11102-024-01408-w · Cited by 14
“Disruption of the normal cortisol circadian rhythm is regarded as the earliest sign of HPA axis dysfunction, and its evaluation is a valuable tool for both primary diagnosis and recurrence of CS [39, 40].”
Machado, M. C., Fragoso, M. C. B. V., Moreira, A. C., Boguszewski, C. L., Vieira, L., Naves, L. A., Vilar, L., de Araújo, L. A., Musolino, N. R. D. C., Miranda, P. A. C., et al. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000014 · Cited by 15
“2-3x/day 1200 mg/day 52% 22 months (6-72) Escape from treatment in 33%; mild common increase in ALT/AST;”
BackgroundMethodApproach to the Patient With Cyclical Cushing Syndrome
Ferrière, A., Nunes, M. L., & Tabarin, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae864 · Cited by 9
Yedinak, C. G., Hopkins, S., Williams, J. N., Ibrahim, A., Cetas, J. S., & Fleseriu, M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00035 · Cited by 9
“It also supports previous studies in the literature that highlight the importance of an early diagnosis of recurrence, thus improving the chances of control; elevated late-night salivary cortisol levels are an early biochemical marker of recurrent CD (5, 13, 14).”
ResultDiurnal salivary cortisol profiles in patients with Cushing's syndrome
Braun, L. T., Vogel, F., Zopp, S., Rubinstein, G., Schilbach, K., Künzel, H., Beuschlein, F., & Reincke, M. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1719-5381 · Cited by 8
“Of the standard screening tests, late-night salivary cortisol seems to be the best test for early detection of the recurrence of Cushing’s disease [5, 6].”
BackgroundAdvancement in perioperative management of pituitary adenomas—Current concepts and best practices
Shafiq, I., Williams, Z. R., & Vates, G. E. (2024) · Journal of Neuroendocrinology · doi:10.1111/jne.13427 · Cited by 8
“98,99 There is no consensus on the utility of using these tests in the immediate postoperative period.”
Persistent Cushing’s Disease after Transsphenoidal Surgery: Challenges and Solutions
Albani, A., & Theodoropoulou, M. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1220-6056 · Cited by 8
Zhou, W., Zheng, S., Ye, L., Su, T., Xie, J., Jiang, L., Jiang, Y., Zhong, X., Wu, L., Zhou, W., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf269 · Cited by 7
Structural and functional brain alterations in Cushing’s disease: A narrative review
Liu, Y.-F., Pan, L., & Feng, M. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.101033 · Cited by 8
Newell-Price, J. D. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00017-9 · Cited by 9
Signs, symptoms and biochemistry in recurrent Cushing disease: a prospective pilot study
Braun, L., Zopp, S., Vogel, F., Honegger, J. B., Rubinstein, G., Schilbach, K., Kunzel, H. E., Beuschlein, F., & Reincke, M. (2021) · Endocrine · doi:10.1007/s12020-021-02719-9 · Cited by 6
Durcan, E., Keskin, F. E., Özkaya, H. M., Şirolu, S., Şahin, S., Korkmaz, Ö. P., Gazioğlu, N., Tanrıöver, N., Çomunoğlu, N., Öz, B., et al. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1523-7216 · Cited by 5
Balderrama-Soto, A., Rivera-Hernández, A. D. J., Reza-Albarrán, A. A., la Vega, A. N.-D., Vergara-López, A., Monteros-Sánchez, A. L. E. D. L., Navas-Minero, C. E., Abreu-Rosario, C., Ramos, D. C., Espinosa-Cárdenas, E., et al. (2026) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.m23000025 · Cited by 6
Endocrine Disturbances Affecting Reproduction
Chang, A. Y., & Auchus, R. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00024-x · Cited by 5
Current challenges in Cushing's syndrome testing: blood, saliva, urine, or hair?
Ferrière, A., & Tabarin, A. (2025) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000923 · Cited by 3
Pan, B., Song, Y. J., Kong, X., Xue, Z., & Guo, Y. (1998) · PubMed · Cited by 2
Cushing’s Disease, Refining the Definition of Remission and Recurrence
Ciporen, J. N., Cetas, J. S., McCartney, S., & Fleseriu, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_12 · Cited by 2
Distinct Late-Night Salivary Cortisol Cut-Off Values for the Diagnosis of Hypercortisolism
van Baal, L., Wichert, M., Zwanziger, D., Dralle, H., Weber, F., Kreitschmann‐Andermahr, I., Führer, D., & Unger, N. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1608-1720 · Cited by 2
Habib, U., Shih, H. A., Biller, B. M. K., & Tritos, N. A. (2025) · Clinical Endocrinology · doi:10.1111/cen.15270 · Cited by 1
“In addition, this test has been shown to be accurate in the evaluation of endocrine remission and recurrence after pituitary surgery [16 – 18].”
Self-citationFleseriu, M., Biller, B. M. K., Bancos, I., Fukuoka, H., Reincke, M., Newell-Price, J. D. C., Melmed, S. K., the Pituitary Society International Cushing Syndrome Delphi Panel Consensus Group, Akirov, A., Araki, T., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag279 · Cited by 1
Self-citationLania, A. G. (2019) · L Endocrinologo · doi:10.1007/s40619-019-00621-1 · Cited by 1
Predictive Value of Steroidal Hormones to Type 2 Diabetes and Metabolic Syndrome
Bunch, D. R. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Posttreatment Management of Cushing’s Disease
Prete, A., & Salvatori, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804340-0.00009-7 · Cited by 1
Evaluation and Follow-Up of Patients With Cushing Disease After Pituitary Surgery
Ferrière, A., Cordroch, C., & Tabarin, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64283-6 · Cited by 2
Swearingen, B. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-11339-1_6
Self-citationPseudo-Cushing’s Syndrome: A Diagnostic Dilemma
Brown, T. V., Belokovskaya, R., & Pessah‐Pollack, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_13
Postoperative endocrinological follow-up
Dekkers, O. M., & Pereira, A. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819949-7.00043-3
Pereira, A. M., & Dekkers, O. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00006-8
Assessment of possibilities for predicting persistent and recurrent course of Cushing’s disease
Андреева, А. В., & Antsiferov, M. B. (2024) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2024-13-1-16-26
Evaluation and follow-up of patients with Cushing disease after pituitary surgery
Ferrière, A., Cordroch, C., & Tabarin, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00146-1
Cortisol salivar noturno no diagnóstico de recidiva em pacientes com Doença de Cushing operados
Alexandre, A. E. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2024.tde-20022025-134110 · Cited by 1
Cushing’s disease: Pituitary tumors causing CS—Diagnosis and treatment
Alcubierre, D. D., Kassi, E., Isidori, A. M., & Hasenmajer, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00010-7
Theodorou, A., Tan, E., Reiner, A. S., Sazo, M., Cohen, M. A., Lin, A. L., Tabar, V. S., & Geer, E. B. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag232
Metadata
- Authors
- Amlashi, F. G., Swearingen, B., Faje, A. T., Nachtigall, L. B., Miller, K. K., Klibanski, A., Biller, B. M. K., & Tritos, N. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Tritos, Nicholas A.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-10
- Volume
- 100
- Issue
- 10
- Pages
- 3770-3777
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1858878141
- Cited by
- 66
- References
- 33
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 3 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 7 · 2018: 9 · 2017: 6 · 2016: 6
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's disease, late-night salivary cortisol, transsphenoidal surgery, postoperative remission, recurrence detection, 24-hour urine free cortisol, diagnostic accuracy, long-term follow-up
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Circadian Rhythm, Female, Follow-Up Studies, Humans, Hydrocortisone, Male, Middle Aged, Postoperative Period, Recurrence, Remission Induction, Retrospective Studies, Saliva, Sensitivity and Specificity, Pituitary ACTH Hypersecretion, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.